Mannatech, Incorporated provides wellness solutions. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through network marketing channels and a Website. It has operations in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Phone972-471-7400
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$173.56 million
Profitability
Miscellaneous
Employees247
Next Earnings Date11/5/2019 (Estimated)
OptionableNot Optionable
Mannatech (NASDAQ:MTEX) Frequently Asked Questions
What is Mannatech's stock symbol?
Mannatech trades on the NASDAQ under the ticker symbol "MTEX."
How often does Mannatech pay dividends? What is the dividend yield for Mannatech?
Mannatech announced a quarterly dividend on Thursday, August 15th. Shareholders of record on Tuesday, September 10th will be given a dividend of $0.125 per share on Tuesday, September 24th. This represents a $0.50 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date of this dividend is Monday, September 9th. View Mannatech's Dividend History.
How will Mannatech's stock buyback program work?
Mannatech declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, November 14th 2018, which allows the company to repurchase $500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 1.3% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its stock is undervalued.
How were Mannatech's earnings last quarter?
Mannatech, Inc. (NASDAQ:MTEX) announced its quarterly earnings results on Wednesday, August, 7th. The company reported $0.81 earnings per share for the quarter. The business had revenue of $40.71 million for the quarter. Mannatech had a negative return on equity of 2.12% and a negative net margin of 0.34%. View Mannatech's Earnings History.
When is Mannatech's next earnings date?
Has Mannatech been receiving favorable news coverage?
Media stories about MTEX stock have trended somewhat positive recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mannatech earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Mannatech.
Are investors shorting Mannatech?
Mannatech saw a decline in short interest during the month of August. As of August 31st, there was short interest totalling 2,400 shares, a decline of 14.3% from the July 31st total of 2,800 shares. Based on an average daily trading volume, of 2,700 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.2% of the shares of the company are sold short. View Mannatech's Current Options Chain.
Who are some of Mannatech's key competitors?
Some companies that are related to Mannatech include True Drinks (TRUU), Mediwound (MDWD), Natural Alternatives International (NAII), Cyanotech (CYAN), FitLife Brands (FTLF), GLG Life Tech (GLGLF), Tauriga Sciences (TAUG), Nutra Pharma (NPHC), Entia Biosciences (ERGO), Beleave (BE), Beleave (BE) and Rock Creek Pharmaceuticals (RCPIQ).
What other stocks do shareholders of Mannatech own?
Who are Mannatech's key executives?
Mannatech's management team includes the folowing people:
- Mr. Alfredo Bala, CEO & Pres (Age 58)
- Mr. Joel R. Bikman, Chief Operating & Marketing Officer (Age 46)
- Mr. David A. Johnson, Chief Financial Officer (Age 49)
- Ms. Erin Kemmler Barta, Gen. Counsel & Corp. Sec. (Age 49)
- Mr. Landen Granvel Fredrick, Chief Global Sales Officer & Pres of North America (Age 46)
Who are Mannatech's major shareholders?
Mannatech's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.29%), Renaissance Technologies LLC (1.23%) and LSV Asset Management (0.44%). Company insiders that own Mannatech stock include Gerald E Gilbert, J Stanley Fredrick, Kevin Andrew Robbins, Larry A Jobe and Robert Toth. View Institutional Ownership Trends for Mannatech.
Which major investors are selling Mannatech stock?
Which major investors are buying Mannatech stock?
MTEX stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and BlackRock Inc.. Company insiders that have bought Mannatech stock in the last two years include Gerald E Gilbert, J Stanley Fredrick, Kevin Andrew Robbins, Larry A Jobe and Robert Toth. View Insider Buying and Selling for Mannatech.
How do I buy shares of Mannatech?
Shares of MTEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Mannatech's stock price today?
One share of MTEX stock can currently be purchased for approximately $16.2752.
How big of a company is Mannatech?
What is Mannatech's official website?
How can I contact Mannatech?
Mannatech's mailing address is 1410 LAKESIDE PARKWAY SUITE 200, FLOWER MOUND TX, 75028. The company can be reached via phone at 972-471-7400 or via email at [email protected]
MarketBeat Community Rating for Mannatech (NASDAQ MTEX)
MarketBeat's community ratings are surveys of what our community members think about Mannatech and other stocks. Vote "Outperform" if you believe MTEX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTEX will underperform the S&P 500 over the long term. You may vote once every thirty days.
